SARS-COV-2 antibodies after booster vaccination. Identification of subgroups with poor response.

Blanca Ayuso García,Eva Romay Lema,Antía Pérez López, Adrián Suárez Piñera,María Del Carmen Pereiro Belay, María José Gude González,Ramón Rabuñal Rey

Revista clinica espanola（2023）

引用 0|浏览0

暂无评分

摘要

Patients treated with antiCD20 drugs, hematologic patients and transplanted patients (mainly lung and kidney) have a higher risk of not achieving post-vaccination immunity. It is essential to identify them in order to individualize and optimize their management.

查看译文

关键词

Antibodies, SARS-CoV-2, Vaccination, Immunity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要